MMP9 and Sepsis: Hoffmann and collaborators reported elevated levels of matrix metalloproteases and their inhibitors (MMP-9, TIMP-2 and TIMP-1) in severe sepsis, and TIMP-1 was suggested as a useful biomarker in predicting the clinical outcome of patients with severe sepsis [76].